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Abstract
Background:  Pleomorphic adenoma of the lacrimal gland is known to undergo malignant
transformation when incompletely excised. Even if such a malignant change occurs, intracranial
direct invasion and leptomeningeal seeding are seldom encountered.
Case presentation: A 50-year-old woman presented with malignant transformation associated
with both intracranial invasion and multiple intracranial and spinal disseminations in the third
recurrence of pleomorphic adenoma of the lacrimal gland, 6 years after initial treatment. MRI
demonstrated increased extent of orbital mass, extending to the cavernous sinus. The patient
underwent intensity-modulated radiation therapy (IMRT) and Gamma Knife radiosurgery. Follow-
up MRI showed multiple leptomeningeal disseminations to the intracranium and spine.
Conclusion: It is important to recognize that leptomeningeal intracranial and spinal disseminations
of pleomorphic adenocarcinoma can occur, although it is extremely rare. To our knowledge, we
report the first case of pleomorphic adenocarcinoma of the lacrimal gland presumably metastasizing
to the intracranium and spine.
Background
Pleomorphic adenomas are the most common benign
epithelial tumors affecting the lacrimal gland [1]; how-
ever, their malignant counterpart, the malignant mixed
tumor, is much less common [2]. Pleomorphic adenoma
is known to recur and also to undergo malignant transfor-
mation when incompletely excised [3,4].
Even if such a malignant change occurs, intracranial direct
invasion and intracerebral and spinal metastases are sel-
dom encountered, because the tumor itself is well demar-
cated [5]. We present a case of malignant transformation
associated with both intracranial invasion and multiple
intracranial and spinal disseminations in the third recur-
rence of pleomorphic adenoma of the lacrimal gland, 6
years after initial treatment. We also describe an initial
experience with gamma knife radiosurgery for intracranial
invasion. To the best of our knowledge, this is the first
report of pleomorphic adenocarcinoma with presumed
multiple intracranial and spinal metastases treated with
Gamma Knife radiosurgery.
Case presentation
A 50-year-old woman had lacrimal mass presented with
progressive exophthalmos and visual disturbance in the
left eye in 2000. Orbital CT scan showed a well-circum-
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scirbed mass at lateral aspect of the left orbit without bone
involvement (Figure 1). She underwent subtotal resection
of a smooth, encapsulated, and multilobulated mass at
the referring hospital. The histological diagnosis was ple-
omorphic adenoma of the lacrimal gland. The clinical
course was uneventful until 4 years after the operation,
when a local recurrence with protrusion of the left eye and
swelling of the left temporal muscle area required subtotal
resection at the Department of Ophthalmology, Yonsei
University Hospital. The mass was extended to periorbital
tissue, lateral orbital rim, and temporal muscle. The histo-
logical diagnosis was poorly differentiated adenocarci-
noma, suggesting malignant carcinomatous changes in
the recurrent pleomorphic adenoma (Figure 2). MRI sur-
veillance of the lesion was initiated. Six months after sec-
ond surgery, MRI demonstrated increased extent of orbital
mass, extending to the cavernous sinus. The patient
underwent intensity-modulated radiation therapy (IMRT)
with two different planning target volumes (PTVs): 1) 45
Gy to extracranial portion, 2) 30 Gy to intracranial por-
tion.
Six month later, the patient complained of the left eye
pain and the left facial paresthesia. An ophthalmological
examination revealed ptosis, exophthalmos, and oph-
thamoplegia of the left eye. Facial sensory change on the
left whole trigeminal territories was noted. MRI revealed a
well-circumscribed mass of the left cavernous sinus
extending to the infratemporal fossa and clivus. The
patient underwent Gamma Knife stereotactic radiosurgery
Contrast-enhanced axial orbital computed tomography showing a well-circumscirbed mass at lateral aspect of the left orbit  without bone involvement Figure 1
Contrast-enhanced axial orbital computed tomography showing a well-circumscirbed mass at lateral aspect of the left orbit 
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with a marginal dose of 15 Gy and maximum dose of 30
Gy to 29.7 ml of tumor volume. Dose was adjusted to the
right optic nerve and optic chiasm (8.4 Gy) and to the left
optic nerve (15 Gy) (Figure 3). Intentional high dose to
the left optic nerve was planned due to useless vision
caused by the left complete occulomtor nerve palsy.
Six months later, follow-up MRI revealed a slightly
decreased tumor size extending to orbital, cavernous
sinus, infratemporal fossa, and clivus. However, small
nodular enhancing lesion on the interhemispheric fissue
and superior cerebellar peduncle, and leptomeningeal
seeding was suspected (Figure 4). Whole spinal MRI was
indicated due to neck and back pain, and it revealed mul-
tiple nodular enhancing masses on the cervico-thoracic
area (Figure 5). Palliative radiotherapy for the intracranial
and spinal metastases was planned, but the patient
refused further active treatment. The patient was dis-
charged and underwent hospice care. Five months later,
the patient died due to pneumonia and sepsis related to
terminal stage of metastatic cancer.
Discussion
Pleormorphic adenoma is the most common benign epi-
thelial lacrimal gland tumor. The incidence of pleomor-
phic adenoma in the literature has been reported as 9–
27% of lacrimal gland tumor [1,3]. Pleomorphic ade-
noma presents an excellent prognosis, particularly follow-
ing complete excision with the pseudocapsule intact [6]. If
the tumor is incompletely removed, recurrence may
occur, usually taking many years to become clinically
apparent. Although recurrent tumors are usually as benign
as the original, some become frankly malignant many
years (mean 17.4) after the initial excision of a pleomor-
Hematoxylin-eosin staining (100× magnification) showing poorly differentiated adenocarcinoma, suggesting malignant carcino- matous changes in the recurrent pleomorphic adenoma Figure 2
Hematoxylin-eosin staining (100× magnification) showing poorly differentiated adenocarcinoma, suggesting malignant carcino-
matous changes in the recurrent pleomorphic adenoma. Nuclear atypia and prominent mitosis are noted.World Journal of Surgical Oncology 2007, 5:29 http://www.wjso.com/content/5/1/29
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phic adenoma [6-11]. The malignant components of ple-
omorphic adenoma are usually carcinomatous, showing
features of either an adenocarcinoma or a poorly differen-
tiated carcinoma, sometimes sarcomatous. Furthermore,
malignant evolution in a tumor recurrence may be associ-
ated with intracranial invasion to the cavernous sinus,
although most recurrences involved only intraorbital
structures. Intracranial infiltration following malignant
transformation in recurrent lacrimal gland tumors have
previously been reported [7-10]. In our case, pleomorphic
adenoma was evolved into both intracranial invasion and
presumed intracranial and spinal disseminations in the
third recurrence of pleomorphic adenoma of the lacrimal
gland.
The recommended treatment for suspected pleomorphic
adenoma of the lacrimal gland is complete surgical resec-
tion or en block excision. However, incomplete or piece-
meal removal of the lesion or rupture of its pseudocapsule
inevitably results in a recurrence, which may evolve malig-
nant changes in the original tumor [8,10]. A biopsy of the
lesion may cause the seeding of tumor cells into the orbit
and a clinical recurrence [12]. Thus, it is emphasized that
complete excision of the lesion within the pseudocapsule
is essential to prevent the potential malignant evolution
in recurrent pleomorphic adenomas [10,11].
The optimal treatment of the malignant mixed tumors
remains controversial. An aggressive approach, such as
orbital exenteration followed by local radiotherapy, is rec-
ommended by some authors [2,13]. However, Polito and
Leccisotti [14] did not find improved survival in patients
submitted to extensive surgery, when compared with
those that underwent more limited local extension. Radi-
ation therapy may be an adjuvant in the management of
extensive or recurrent pleomorphic adenomas even fol-
Showing the treatment plan of gamma knife radiosurgey Figure 3
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lowing complete excision. On the other hand, it could be
argued that radiation therapy is of little value as a salvage
procedure for recurrent or residual malignant mixed
tumors [15]. Although irradiation can provide short-term
palliation, it achieves little in terms of long-term tumor
control. Chemotherapy may occasionally be clinically
efficacious for the recurrence of pleomorphic adenoma
[10,11]. In present case, local control was achieved by
Follow-up brain MR images revealing a slightly decreased tumor size extending to orbital, cavernous sinus, infratemporal fossa,  and clivus Figure 4
Follow-up brain MR images revealing a slightly decreased tumor size extending to orbital, cavernous sinus, infratemporal fossa, 
and clivus. However, small nodular enhancing lesion on the interhemispheric fissue and superior cerebellar peduncle, and lep-
tomeningeal seeding is suspected.
Spinal sagittal MR images (A: cervical, B: thoracic) revealing multiple nodular enhancing masses on the cervico-thoracic area Figure 5
Spinal sagittal MR images (A: cervical, B: thoracic) revealing multiple nodular enhancing masses on the cervico-thoracic area.Publish with BioMed Central    and   every 
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IMRT and gamma knife radiosurgery, but leptomeningeal
seedings were encountered even though local control was
more or less successful.
The malignant tumors following an intermediate course
and are associated with a median survival of 12 years and
a 15-year survival rate of 46% [5,11,16]. In contrast,
patients with tumor recurrence particularly associated
with intracranial invasion following malignant changes
have a median survival of less than 5 years [7-9]. This
patient died 17 months after the first intracranial exten-
sion and 6 years after the first operation.
Conclusion
To our knowledge, we report the first case of pleomorphic
adenocarcinoma of the lacrimal gland presumably metas-
tasizing to the intracranium and spine. Our initial experi-
ence with intensity-modulated radiation therapy and
Gamma Knife radiosurgery for intracranial direct invasion
of the pleomorphic adenocarcinoma was of little value for
as a salvage procedure for malignant transformation of
pleomorphic adenoma. This case emphasize that com-
plete excision of the original lesion is essential to prevent
the potential malignant evolution in recurrent pleomor-
phic adenomas.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
JYA  conceptualized the study, gathered the data and
drafted the manuscript. JHC participated in Gamma Knife
radiosurgery and took charge of post-operative manage-
ments together with JYA. SHK carried out the pathologic
studies. KSL supervised the process and finally approved
the manuscript for been published. All authors have read
and approved the final manuscript.
Acknowledgements
Written consent was obtained from the patient for publication of this case 
report.
References
1. Shields CL, Shields JA, Eagle RC, Rathmel JP: Clinicopathologic
review of 142 cases of lacrimal gland lesions.  Ophthalmology
1989, 96:431-435.
2. Font RL, Smith SL, Bryan RG: Malignant epithelial tumors of the
lacrimal gland: a clinicopathologic study of 21 cases.  Arch Oph-
thalmol 1998, 116:613-616.
3. Shields CL, Shields JA: Lacrimal gland tumours.  Int Ophthalmol Clin
1993, 33:181-188.
4. Rose GE, Wright JE: Pleomorphic adenoma of the lacrimal
gland.  Br J Ophthalmol 1992, 76:395-400.
5. Forrest AW: Pathologic criteria for effective management of
epithelial lacrimal gland tumors.  Am J Ophthalmol 1971,
71:178-192.
6. Zimmerman LE, Sanders TE, Ackerman LV: Epithelial tumors of
the lacrimal gland: prognostic and therapeutic significance of
histologic types.  Int Ophthalmol Clin 1962, 2:337-367.
7. Ni C, Cheng SC, Dryja TP, Cheng TY: Lacrimal gland tumours.
Int Ophthalmol Clin 1982, 22:99-120.
8. Perzin KH, Jakobiec FA, Livolsi V, Desjardins L: Lacrimal gland
malignant mixed tumors (carcinomas arising in benign
mixed tumors): a clinico-pathologic study.  Cancer 1980,
45:2593-2606.
9. Riley FC, Henderson JW: Report of a case of malignant transfor-
mation in benign mixed tumor of the lacrimal gland.  Am J
Ophthalmol 1970, 70:767-771.
10. Yamasaki T, Kikuchi H, Yamabe H, Yamashita J: Multiple intracra-
nial metastases following malignant evolution in recurrent
pleomorphic adenoma of the lacrimal gland.  Neurol Med Chir
(Tokyo) 1990, 30:1038-1042.
11. Henderson JW, Farrow GM: Primary malignant mixed tumors
of the lacrimal gland.  Ophthalmology 1980, 87:466-475.
12. Lloyd GA: Lacrimal gland tumours: the role of CT and con-
ventional radiology.  Br J Radiol 1981, 54:1034-1038.
13. Wright JE, Rose GE, Garner A: Primary malignant neoplasms of
the lacrimal gland.  Br J Ophthalmol 1992, 76:401-407.
14. Polito E, Leccisotti A: Epithelial malignancies of the lacrimal
gland: survival rates after extensive and conservative ther-
apy.  Ann Ophthalmol 1993, 25:422-426.
15. Brada M, Henk JM: Radiotherapy for lacrimal gland tumors.
Radiother Oncol 1987, 9:175-183.
16. Janecka I, Housepian E, Trokel S, Rankow R, Jones I, Jakobiec F: Sur-
gical management of malignant tumors of the lacrimal
gland.  Am J Surg 1984, 148:539-541.